SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $370,000 | +66.7% | 4,114 | +71.4% | 0.00% | +50.0% |
Q3 2021 | $222,000 | +13.3% | 2,400 | -4.8% | 0.00% | +100.0% |
Q2 2021 | $196,000 | +4800.0% | 2,522 | +4750.0% | 0.00% | – |
Q1 2021 | $4,000 | -99.3% | 52 | -98.3% | 0.00% | -100.0% |
Q4 2020 | $536,000 | -85.8% | 3,142 | -93.7% | 0.01% | -89.4% |
Q3 2019 | $3,766,000 | -57.0% | 50,000 | -37.7% | 0.05% | -54.8% |
Q4 2018 | $8,753,000 | – | 80,211 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |